These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. Weber KT J Lab Clin Med; 2003 Aug; 142(2):71-82. PubMed ID: 12960953 [TBL] [Abstract][Full Text] [Related]
4. Aldosterone and antialdosterone therapy in congestive heart failure. Weber KT; Villarreal D Am J Cardiol; 1993 Jan; 71(3):3A-11A. PubMed ID: 8422002 [TBL] [Abstract][Full Text] [Related]
5. Aldosterone antagonists in hypertension and heart failure. Mantero F; Lucarelli G Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593 [TBL] [Abstract][Full Text] [Related]
6. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure. Adams KF Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833 [TBL] [Abstract][Full Text] [Related]
7. [Aldosterone and its antagonists in heart failure]. Lopes ME; Le Corvoisier P; Tabet JY; Su JB; Badoual T; Cachin JC; Merlet P; Castaigne A; Hittinger L Presse Med; 2003 Jan; 32(2):79-87. PubMed ID: 12653034 [TBL] [Abstract][Full Text] [Related]
8. Aldosterone: cardiovascular assault. Struthers AD Am Heart J; 2002 Nov; 144(5 Suppl):S2-7. PubMed ID: 12422134 [TBL] [Abstract][Full Text] [Related]
10. Aldosterone antagonism and congestive heart failure: a new look at an old therapy. Thohan V; Torre-Amione G; Koerner MM Curr Opin Cardiol; 2004 Jul; 19(4):301-8. PubMed ID: 15218387 [TBL] [Abstract][Full Text] [Related]
12. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure]. Christ M; Ludwig N; Maisch B Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459 [TBL] [Abstract][Full Text] [Related]
13. Eplerenone in the treatment of chronic heart failure. Krum H; Liew D Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure. Nappi JM; Sieg A Vasc Health Risk Manag; 2011; 7():353-63. PubMed ID: 21731887 [TBL] [Abstract][Full Text] [Related]
15. Aldosterone in heart failure: pathophysiology and treatment. Struthers AD Curr Heart Fail Rep; 2004 Dec; 1(4):171-5. PubMed ID: 16036041 [TBL] [Abstract][Full Text] [Related]
16. Aldosterone and aldosterone antagonism in cardiovascular disease: focus on eplerenone (Inspra). Stier CT; Koenig S; Lee DY; Chawla M; Frishman WH Heart Dis; 2003; 5(2):102-18. PubMed ID: 12713678 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone as a mediator in cardiovascular injury. Stier CT; Chander PN; Rocha R Cardiol Rev; 2002; 10(2):97-107. PubMed ID: 11895576 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663 [TBL] [Abstract][Full Text] [Related]
19. The endothelin-aldosterone axis and cardiovascular diseases. Rossi GP; Cavallin M; Nussdorfer GG; Pessina AC J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S49-52. PubMed ID: 11811378 [TBL] [Abstract][Full Text] [Related]
20. New treasures from old? EPHESUS. Eplerenome Post-AHI Heart Failure Efficacy and Survival Study. Pfeffer MA Cardiovasc Drugs Ther; 2001 Jan; 15(1):11-3. PubMed ID: 11504157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]